Morgan Stanley Rani Therapeutics Holdings, Inc. Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Rani Therapeutics Holdings, Inc. stock. As of the latest transaction made, Morgan Stanley holds 7,020 shares of RANI stock, worth $3,720. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,020

Previous 14,586 51.87%

Holding current value

$3,720

Previous $18,000 83.33%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	SELL	$0.48 - $1.39 $3,631 - $10,516	-7,566 Reduced 51.87%	7,020 $3,000
Q1 2025 May 15, 2025	BUY	$1.25 - $1.85 $10,106 - $14,957	8,085 Added 124.37%	14,586 $18,000
Q4 2024 Feb 14, 2025	BUY	$1.3 - $3.18 $1,625 - $3,975	1,250 Added 23.8%	6,501 $8,000
Q3 2024 May 14, 2025	BUY	$2.06 - $3.99 $4,738 - $9,177	2,300 Added 77.94%	5,251 $11,000
Q3 2024 Nov 14, 2024	BUY	$2.06 - $3.99 $4,738 - $9,177	2,300 Added 77.94%	5,251 $11,000
Q2 2024 May 14, 2025	SELL	$3.13 - $7.85 $11,111 - $27,867	-3,550 Reduced 54.61%	2,951 $11,000
Q2 2024 Oct 17, 2024	BUY	$3.13 - $7.85 $1,565 - $3,925	500 Added 20.4%	2,951 $11,000
Q2 2024 Aug 14, 2024	BUY	$3.13 - $7.85 $1,565 - $3,925	500 Added 20.4%	2,951 $11,000
Q1 2024 Oct 17, 2024	SELL	$2.98 - $3.8 $1,490 - $1,900	-500 Reduced 16.94%	2,451 $7,000
Q1 2024 Aug 16, 2024	SELL	$2.98 - $3.8 $8,195 - $10,450	-2,750 Reduced 52.87%	2,451 $7,000
Q1 2024 May 15, 2024	SELL	$2.98 - $3.8 $8,195 - $10,450	-2,750 Reduced 52.87%	2,451 $7,000
Q4 2023 Aug 16, 2024	BUY	$1.85 - $3.67 $4,162 - $8,257	2,250 Added 76.25%	5,201 $17,000
Q4 2023 Feb 13, 2024	BUY	$1.85 - $3.67 $7,956 - $15,784	4,301 Added 477.89%	5,201 $17,000
Q3 2023 Nov 15, 2023	SELL	$2.17 - $4.44 $2,191 - $4,484	-1,010 Reduced 52.88%	900 $1,000
Q2 2023 Aug 14, 2023	BUY	$3.92 - $5.58 $5,409 - $7,700	1,380 Added 260.38%	1,910 $7,000
Q1 2023 May 15, 2023	SELL	$5.07 - $6.89 $8,314 - $11,299	-1,640 Reduced 75.58%	530 $2,000
Q4 2022 Feb 14, 2023	SELL	$5.51 - $10.02 $14,017 - $25,490	-2,544 Reduced 53.97%	2,170 $12,000
Q3 2022 Nov 14, 2022	BUY	$8.23 - $12.4 $5,069 - $7,638	616 Added 15.03%	4,714 $45,000
Q2 2022 Oct 27, 2022	BUY	$8.0 - $14.25 $6,560 - $11,685	820 Added 25.02%	4,098 $43,000
Q2 2022 Aug 15, 2022	BUY	$8.0 - $14.25 $6,560 - $11,685	820 Added 25.02%	4,098 $43,000
Q1 2022 Oct 27, 2022	SELL	$12.21 - $23.14 $10,012 - $18,974	-820 Reduced 20.01%	3,278 $44,000
Q1 2022 May 13, 2022	SELL	$12.21 - $23.14 $6,043 - $11,454	-495 Reduced 13.12%	3,278 $44,000
Q4 2021 Feb 14, 2022	BUY	$16.09 - $35.0 $60,707 - $132,055	3,773 New	3,773 $61,000

Others Institutions Holding RANI

# of Institutions

Shares Held

6.32M

Call Options Held

29.4K

Put Options Held

View Full List

About Rani Therapeutics Holdings, Inc.

Ticker RANI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,492,000
Market Cap $13M
Description
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...

More about RANI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account